Waxman Act News Today

I. Introduction - No pharmaceutical antitrust decision has had more impact than the Supreme Court’s 2013 decision in Federal Trade Commission v. Actavis, a decision which...

Reverse payment cases arise in the context of settlement agreements between brand-name pharmaceutical companies and generic drug manufacturers to resolve patent litigation under the Hatch-Waxman Act...

More than a decade ago Congress considered, and rejected, any standing requirements for post-grant proceedings. Congress could hardly have been more explicit. The provisions were...

U.S. govt largely to blame for high drug prices: USA Today-

A lot of people, including President Joe Biden, blame corporate greed for high prescription costs. But its not that simple.

Both federal and state policymakers are focused on prescription drug costs, responding to perceptions by many Americans that costs are too high and do not provide sufficient value for their price.

In recent decades, U.S. and foreign biopharmaceutical companies (makers of drugs that are based on chemical compounds or biological materials, such as vaccines) and medical device manufacturers have been responsible for many cures and advances in treatment that have benefited patients’ lives. New cancer treatments, medical devices, and other medical discoveries are being made at a rapid pace.

The man who forged successful alliances with Democratic health giants, such as Sen. Kennedy and Rep. Waxman, fell back on his deep conservative roots as opposition grew to the Affordable Care Act.

The man who forged successful alliances with Democratic health giants, such as Sen. Kennedy and Rep. Waxman, fell back on his deep conservative roots as opposition grew to the Affordable Care Act.

The man who forged successful alliances with Democratic health giants, such as Sen. Kennedy and Rep. Waxman, fell back on his deep conservative roots as opposition grew to the Affordable Care Act.